DNA guanine O⁶ position (O⁶-G) (O⁶-G)

The DNA guanine O⁶ position is a critical nucleophilic site within the DNA double helix that serves as the primary target for alkylating chemotherapeutic agents such as temozolomide and nitrosoureas [PubChem; NIH NCI]. Alkylation at this position, particularly methylation, creates O⁶-methylguanine lesions that are highly cytotoxic to cancer cells [PubMed: 15150602]. These lesions are lethal because they frequently mispair with thymine during DNA replication, which triggers the cellular mismatch repair (MMR) system to initiate a futile cycle of repair that results in double-strand breaks and apoptosis [Nature Reviews Cancer, 2004]. The effectiveness of drugs targeting this site is largely determined by the presence of the repair enzyme O⁶-methylguanine-DNA methyltransferase (MGMT), which can remove the alkyl group and restore the DNA, leading to drug resistance [UniProt: P16455]. Consequently, the methylation status of the MGMT promoter is a vital clinical biomarker for predicting response to therapy in patients with glioblastoma [NEJM, 2005]. However, because these drugs also alkylate DNA in healthy tissues, they are associated with significant toxicities, including severe myelosuppression and an increased risk of developing secondary leukemias [FDA: Temozolomide Label].

Other names

O6-alkylguanineO6-methylguanine siteGuanine O6 position

Alkylating agents transfer alkyl groups to the O6 position of guanine, creating O6-alkylguanine [PubChem]. This lesion mispairs with thymine during DNA replication [PubMed: 15150602]. The mismatch is recognized by the mismatch repair (MMR) system, which leads to double-strand breaks and apoptosis [Nature Reviews Cancer, 2004].